Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy
Taj MohammadCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, IndiaAnas ShamsiCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, IndiaSaleha AnwarCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, IndiaMohd UmairDepartment of Computer Science, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, IndiaAfzal HussainDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi ArabiaMd Tabish RehmanDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi ArabiaMohamed F. AlajmiDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi ArabiaAsimul IslamCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, IndiaMd. Imtaiyaz HassanCentre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, 110025, India. Electronic address: [email protected]
2020en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba